hepaticojejunostomia

Hepaticojejunostomia is a surgical procedure used to create an artificial bile duct between the liver and the small intestine. This procedure is typically performed to treat conditions where the natural bile ducts are obstructed or damaged, preventing bile from flowing from the liver to the intestines. Common indications for hepatocystojejunostomia include primary sclerosing cholangitis, choledochal cysts, and strictures of the bile duct.

The procedure involves making an incision in the liver to expose the bile ducts and then creating a small opening in the jejunum, the third segment of the small intestine. A small tube, known as a stent, is placed between the liver and the jejunum to allow bile to flow from the liver into the intestine. This creates a new pathway for bile to reach the intestines, bypassing the obstructed or damaged bile ducts.

Hepaticojejunostomia is often considered a last resort when other treatments, such as endoscopic retrograde cholangiopancreatography (ERCP) or surgical bypasses, have failed. The success of the procedure depends on several factors, including the underlying cause of the bile duct obstruction and the patient's overall health. Post-operative care typically involves monitoring for complications such as infection, bleeding, and bile leaks.

The procedure has been used for decades and has shown varying degrees of success in improving symptoms and quality of life for patients with biliary obstruction. However, it is important to note that hepatocystojejunostomia is not without risks and may not be suitable for all patients. Consultation with a healthcare provider is essential to determine the best course of treatment.